Ethical Investing Can Play Larger Role In Fight Against Antimicrobial Resistance, England Chief Medical Officer Says

The Telegraph: Ethical investments could help in fight against superbugs, says chief medical officer
“Investors are being urged to put their money into companies that are developing new antibiotics and vaccines as a way of curbing the rise of superbugs. Dame Sally Davies, chief medical officer for England and a key figure in the global fight against superbugs, told a conference on antimicrobial resistance (AMR) that ethical investment was one way of tackling the problem…” (Gulland, 3/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.